126 related articles for article (PubMed ID: 34957683)
1. Mesothelioma with ALK gene mutations in two pediatric patients: Clinical course and outcome.
Kimpo MS; Francisco KL; Chong QT; Lian DWQ; Lin NY; Mali V; Loh DL; Prabhakharan K
Pediatr Blood Cancer; 2022 Jul; 69(7):e29544. PubMed ID: 34957683
[No Abstract] [Full Text] [Related]
2. Status of Anaplastic Lymphoma Kinase (ALK) in malignant mesothelioma.
Varesano S; Leo C; Boccardo S; Salvi S; Truini M; Ferro P; Fedeli F; Canessa PA; Dessanti P; Pistillo MP; Roncella S
Anticancer Res; 2014 May; 34(5):2589-92. PubMed ID: 24778081
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum.
Loharamtaweethong K; Puripat N; Aoonjai N; Sutepvarnon A; Bandidwattanawong C
Histopathology; 2016 Mar; 68(4):603-7. PubMed ID: 26179668
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma.
Mian I; Abdullaev Z; Morrow B; Kaplan RN; Gao S; Miettinen M; Schrump DS; Zgonc V; Wei JS; Khan J; Pack S; Hassan R
J Thorac Oncol; 2020 Mar; 15(3):457-461. PubMed ID: 31783178
[TBL] [Abstract][Full Text] [Related]
5. ALK in Mesothelioma: To FISH or Not to FISH?
Cornelissen R; Dubbink HJ; von der Thüsen JH
J Thorac Oncol; 2020 Oct; 15(10):e168-e169. PubMed ID: 32981606
[No Abstract] [Full Text] [Related]
6. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
[TBL] [Abstract][Full Text] [Related]
7. NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.
Leal JL; Peters G; Szaumkessel M; Leong T; Asadi K; Rivalland G; Do H; Senko C; Mitchell PL; Quing CZ; Dobrovic A; Thapa B; John T
Lung Cancer; 2020 Aug; 146():154-159. PubMed ID: 32540558
[TBL] [Abstract][Full Text] [Related]
8. FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma.
Salvi S; Varesano S; Boccardo S; Ravetti JL; Canessa PA; Pistillo MP; Ferro P; Fedeli F; Roncella S
J Thorac Oncol; 2017 Aug; 12(8):e116-e118. PubMed ID: 28748818
[No Abstract] [Full Text] [Related]
9. ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement.
Kim H; Park E; Kim YJ; Chung JH
Virchows Arch; 2013 May; 462(5):597-9. PubMed ID: 23605565
[No Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.
Ko SJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Chung JH; Kim TJ; Lee KW; Kim K; Jheon S; Kim H; Lee JH; Lee CT
BMC Cancer; 2014 May; 14():312. PubMed ID: 24885886
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samples.
Abe H; Kawahara A; Azuma K; Taira T; Takase Y; Fukumitsu C; Murata K; Yamaguchi T; Akiba J; Ishii H; Okamoto I; Hoshino T; Takamori S; Kage M
J Thorac Oncol; 2015 May; 10(5):800-805. PubMed ID: 25898958
[TBL] [Abstract][Full Text] [Related]
12. Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements.
Park S; Park TS; Choi CM; Lee DH; Kim SW; Lee JS; Kim WS; Song JS; Lee JC
Clin Lung Cancer; 2015 Sep; 16(5):e83-9. PubMed ID: 25682546
[TBL] [Abstract][Full Text] [Related]
13. Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report.
Hu J; Zhang B; Yao F; Fu Y; Chen D; Li D; Du N; Lizaso A; Song J; Zhang L; Li X
Ther Adv Respir Dis; 2020; 14():1753466620935770. PubMed ID: 32600123
[No Abstract] [Full Text] [Related]
14. Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations.
Lou NN; Zhang XC; Chen HJ; Zhou Q; Yan LX; Xie Z; Su J; Chen ZH; Tu HY; Yan HH; Wang Z; Xu CR; Jiang BY; Wang BC; Bai XY; Zhong WZ; Wu YL; Yang JJ
Oncotarget; 2016 Oct; 7(40):65185-65195. PubMed ID: 27533086
[TBL] [Abstract][Full Text] [Related]
15. Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib.
Hayashi N; Fujita A; Saikai T; Takabatake H; Sotoshiro M; Sekine K; Kawana A
Intern Med; 2018 Mar; 57(5):713-716. PubMed ID: 29151522
[TBL] [Abstract][Full Text] [Related]
16. The continuum of care for ALK-positive NSCLC: from diagnosis to new treatment options - an overview.
Solomon B; Soria JC
Ann Oncol; 2016 Sep; 27 Suppl 3():iii1-iii3. PubMed ID: 27573751
[No Abstract] [Full Text] [Related]
17. Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma.
Ren S; Chen X; Kuang P; Zheng L; Su C; Li J; Li B; Wang Y; Liu L; Hu Q; Zhang J; Tang L; Li X; Zhou C; Schmid-Bindert G
Cancer; 2012 Nov; 118(22):5588-94. PubMed ID: 22569898
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significance.
Toyokawa G; Seto T
Respir Investig; 2014 Nov; 52(6):330-8. PubMed ID: 25453376
[TBL] [Abstract][Full Text] [Related]
19. The role of anaplastic lymphoma kinase in pediatric cancers.
Takita J
Cancer Sci; 2017 Oct; 108(10):1913-1920. PubMed ID: 28756644
[TBL] [Abstract][Full Text] [Related]
20. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]